There’s some good news for President Trump amid economic and legal uncertainty over his tariff agenda. The administration has an agreement under which the United Kingdom’s National Health Service will increase the prices it pays for new, patented U.S. medicine by 25 percent while lowering the concessions it demands from U.S. drugmakers under various rebate schemes. In return, the United […]
Author Archives: Satya Marar
Satya Marar is a a visiting postgraduate fellow at the Mercatus Center at George Mason University. He wrote this for InsideSources.com.
